NIJMEGEN, Netherlands--(BUSINESS WIRE)--Aiosyn, a medical software company that develops AI-powered pathology solutions, has been awarded a EUR 1.300.000 EFRO-OOST grant alongside Radboud university medical center and Pathologie-DNA to...

The Institute of Human Biology aims to better predict which drug candidates are safe and most effective in patients by evolving and increasing the use of human model systems. Human model systems are miniature living 'replicas' of...

NEW YORK--(BUSINESS WIRE)--Paige, a global leader in end-to-end digital pathology solutions and clinical AI applications to assist in diagnosing cancer, today announced it is working with Visiopharm, an artificial intelligence (AI)-driven...

NIJMEGEN, The Netherlands--(BUSINESS WIRE)--Aiosyn, a software company that develops AI-powered pathology software, has announced the integration of its AI-powered automated quality control (QC) algorithm in the Sectra Amplifier Marketplace....

Xtalks: Featured speaker from Proscia will share real-world examples and use cases during free event. TORONTO, ONTARIO, CANADA (PRWEB) MAY 01, 2023 Preclinical research and development (R&D) centers around workflows that generate more...

Aiforia has received a funding decision from Business Finland to accelerate the development of AI-assisted software solutions for clinical pathology and drug development 27 April 2023 at 12:00 a.m. EEST. Aiforia has received a funding...